31796 Federal Register / Vol. 75, No. 107 / Friday, June 4, 2010 / Notices 

under Section III–A–1 of the NIH 

Guidelines for Research Involving 

Recombinant DNA Molecules (NIH 

Guidelines). 

SUMMARY: Notice of a discussion of a 

proposed action under Section III–A–1 

published on May 24, 2010 (75 FR 

28811) is withdrawn. The discussion 

that was to be held at the June 16–17, 

2010 meeting of the NIH Recombinant 

DNA Advisory Committee has been 

deferred at the request of the principal 

investigator. 

FOR FURTHER INFORMATION CONTACT: 

OBA by e-mail at oba@od.nih.gov, or 

telephone at 301–496–9838, if you have 

questions, or require additional 

information. 

Dated: May 26, 2010. 

Jacqueline Corrigan-Curay, 

Acting Director, Office of Biotechnology 

Activities, National Institutes of Health. 

[FR Doc. 2010–13484 Filed 6–3–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; ARRA: 

AIDS and Related Research Competitive 

Revisions. 

Date: June 17, 2010. 

Time: 4 p.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Mark P. Rubert, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1775, rubertm@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Tooth 

Development, Mobility and Mineralization. 

Date: June 23, 2010. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Priscilla B. Chen, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4104, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1787, chenp@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: June 2, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–13453 Filed 6–3–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Advisory Board, June 21, 2010, 6:30 

p.m. to June 23, 2010, 12 p.m., National 

Institutes of Health, Building 31, 31 

Center Drive, Bethesda, MD 20892 

which was published in the Federal 

Register on May 11, 2010, FR 26267– 

26268. 

This Federal Register Notice is being 

amended to change the date, times, and 

location of the meeting of the Ad Hoc 

Subcommittee on Experimental 

Therapeutics to June 22, 2010 from 12 

p.m. to 1 p.m. at the National Institutes 

of Health, Building 31, 31 Center Drive, 

Conference Room 7, Bethesda, MD 

20892 and to add the meeting of the 

Subcommittee on Clinical Investigations 

to June 21, 2010 from 6 p.m. to 7:30 

p.m. at Embassy Suites, Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Dated: May 28, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–13451 Filed 6–3–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Coordination Core for Programs to Increase 

Diversity Among Individuals Engaged in 

Health-Related Research (PRIDE). 

Date: June 16, 2010. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Stephanie J Webb, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7196, 

Bethesda, MD 20892, 301–435–0291, 

stephanie.webb@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Atherosclerosis Risk in Communities (ARIC) 

Study—Field Centers. 

Date: June 24, 2010. 

Time: 1:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Tony L Creazzo, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7180, 

Bethesda, MD 20892–7924, 301–435–0725, 

creazzot@mail.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Atherosclerosis Risk in Communities (ARIC) 

Study—Central Laboratory Center. 

Date: June 24, 2010. 

Time: 3:30 p.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Tony L Creazzo, PhD, 

Scientific Review Officer, Review Branch/ 


srobinson on DSKHWCL6B1PROD with NOTICES